Medical Communications

Showing 15 posts of 6408 posts found.

shutter

Japan approves Gilead and Eisai’s Jyseleca for rheumatoid arthritis

September 25, 2020 Medical Communications, Sales and Marketing Eisai, Gilead, Japan, Jyseleca

Gilead and Eisai have secured approval for their oral JAK1 preferential inhibitor Jyseleca (filgotinib) from the Japanese Ministry of Health, …
shutterstock_2

GSK confirms deal to supply 300 million COVID-19 vaccine doses to the EU

September 25, 2020 Manufacturing and Production, Medical Communications COVID-19, EU, GSK, Vaccine

GlaxoSmithKline has confirmed a new COVID-19 vaccine supply deal to deliver 300 million doses of its candidate to the European …
donald_trump_29496131773_1

Trump approves plan to make the import of Canadian drugs easier

September 25, 2020 Medical Communications

President Trump has outlined his “America First Health Plan” on Thursday, which will allow the easy importation of prescription drugs …
800px-winn_army_community_hospital_pharmacy_stays_online_during_power_outage_1

British consumers have increasingly turned to community pharmacies during COVID-19

September 25, 2020 Medical Communications

British consumers have increasingly turned to community pharmacies during the coronavirus pandemic, according to a new study. Research conducted by …
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

September 25, 2020 Medical Communications

The top 10 news stories this week focus on coronavirus vaccine trials, as around one in seven patients who have …
credit_-_carl_recine__reuters

COVID-19 track and trace app launched in England and Wales after months of delays

September 24, 2020 Medical Communications, Sales and Marketing UK, VOCID-19, app, test and trace

The UK Government’s track and trace app for COVID-19 has finally launched in England and Wales, after months of delays …
libtayo

Promising Phase 2 data for Sanofi and Regeneron’s PD-1 inhibitor Libtayo in locally advanced basal cell carcinoma

September 18, 2020 Medical Communications, Research and Development Cancer, ESMO 2020, Libtayo, Regeneron, Sanofi, pharma

Promising Phase 2 data has been released at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 for Sanofi …
800px-lt

Roche says its rheumatoid arthritis drug reduces the need for ventilators in coronavirus patients

September 18, 2020 Medical Communications COVID-19, Roche

Roche says that its Actermra/Roactemra drugs reduce the likelihood that coronavirus patients with virus-related pneumonia will need to be put …
256px-mikhail_murashko_2020-01-29

One in seven Russian COVID-19 vaccine recipients display side-effects, says Health Minister

September 18, 2020 Medical Communications, Research and Development COVID-19, Russia, Sputnik V, Vaccine

Around one in seven patients who have received Russia’s vaccine against COVID-19 have displayed side-effects in clinical studies, according to …
800px-jnjioffice

New York files $2 billion lawsuit against J&J for downplaying risks of opioids in its marketing

September 18, 2020 Medical Communications new york state, opioid crisis

New York State is suing Johnson & Johnson in a lawsuit seeking $2 billion in damages for the company’s role …
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

September 18, 2020 Medical Communications

The top ten news stories this week centre around coronavirus vaccines, with Russia signing a deal with an Indian pharma …
spotlighton-aprile-cw_covid-19-and-cancer-1-img

Oncology research in the age of COVID-19

September 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, pharma

Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive …
james_caggiano

Targazyme snaps up new CEO

September 11, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targazyme, appointment

Experienced industry executive James Caggiano has been named as the new head of Californian biotech Targazyme, who will take up …
astrazeneca_sign_sky

NICE U-turns to approve AstraZeneca’s Tagrisso in two new lung cancer indications

September 11, 2020 Medical Communications, Sales and Marketing AstraZeneca, NICE, Tagrisso

NICE has announced the recommendation of AstraZeneca’s Tagrisso (osimertinib) for routine use on the NHS in England and Wales in …

Roche and Novartis fined a collective €444 million in France for abusive practices

September 11, 2020 Medical Communications eye medicine, eye treatment

Novartis and Roche have been fined €444 million in France for abusive practices the companies implemented to push Lucentis over …
The Gateway to Local Adoption Series

Latest content